Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongluo Huayu Formula Combined With Western Medicine for Retinal Vein Occlusion
NCT07718503Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised trial in retinal vein occlusion (RVO) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Central Macular Thickness at 6 months. Planned start Jun 2026; status: not yet recruiting.
02
Conditions
retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT07718503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07718503.